Mangoceuticals issues 33,333 shares under ELOC and converts 200 Series B shares into 93,299 common shares

MANGOCEUTICALS, INC.

Sold 33,333 shares at $2.36 each for net proceeds of $78,787 under the $25M ELOC with Platinum Point Capital.
Converted 200 Series B Preferred shares into 93,299 common shares at $2.358/share, value $220,000.
Both issuances exempt from registration under Securities Act (Section 4(a)(2)/Rule 506 and Section 3(a)(9)).
Resale of shares under ELOC and conversion are covered by effective registration statements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.